503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
19.75%
Revenue growth exceeding 1.5x CRWD's 5.94%. David Dodd would verify if faster growth reflects superior business model.
17.92%
Cost growth above 1.5x CRWD's 7.31%. Michael Burry would check for structural cost disadvantages.
20.01%
Gross profit growth exceeding 1.5x CRWD's 5.45%. David Dodd would verify competitive advantages.
0.21%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.51%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
20.82%
Total costs growth above 1.5x CRWD's 4.38%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
42.91%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
20.39%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
0.95%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
17.93%
Operating income growth exceeding 1.5x CRWD's 9.37%. David Dodd would verify competitive advantages.
-1.52%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
9.24%
Other expenses growth less than half of CRWD's 18.80%. David Dodd would verify if advantage is sustainable.
17.54%
Similar pre-tax income growth to CRWD's 20.26%. Walter Schloss would investigate industry trends.
-1.85%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
17.60%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
17.51%
Net income growth 50-75% of CRWD's 29.52%. Martin Whitman would scrutinize operations.
-1.88%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
25.00%
Similar EPS growth to CRWD's 29.55%. Walter Schloss would investigate industry trends.
25.00%
Similar diluted EPS growth to CRWD's 29.55%. Walter Schloss would investigate industry trends.
-7.81%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-7.81%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.